Showing results (281-290 of 686) with videos related to

Sort By:
Pageof 69
Gastroenterology|May 13, 2008
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndromeArun J Sanyal, Thomas Boyer, Guadalupe Garcia-Tsao, et al.
Hepatoma Research|November 24, 2022
The transcontinental variability of nonalcoholic fatty liver diseaseClaudia P Oliveira, Angelo Paredes, Mohammed Siddiqui, et al.
Hepatology (Baltimore, Md.)|March 29, 2012
Association of AKI with mortality and complications in hospitalized patients with cirrhosisJustin M Belcher, Guadalupe Garcia-Tsao, Arun J Sanyal, et al.
Molecular Pharmacology|December 22, 2012
5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse modelLeyuan Xu, Jin Koung Kim, Qianming Bai, et al.
Cell Death and Differentiation|April 29, 2014
Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosisS C Cazanave, X Wang, H Zhou, et al.
Hepatology (Baltimore, Md.)|June 17, 2020
From NAFLD to MAFLD: Implications of a Premature Change in TerminologyZobair M Younossi, Mary E Rinella, Arun J Sanyal, et al.
Gastroenterology|March 1, 1997
The natural history of portal hypertension after transjugular intrahepatic portosystemic shuntsA J Sanyal, A M Freedman, V A Luketic, et al.
Journal of Clinical Lipidology|November 13, 2023
Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemiaAnurag Mehta, Terence B Lee, Pamela Alebna, et al.
Pageof 69